(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stock indexes rose on Tuesday after data showed retail sales continued to rise in August but gains were capped by caution ahead of this week's Federal Reserve meeting. The Dow Jones industrial average was up 1.00 percent at 16,535.28, the S&P 500 was up 0.87 percent at 1,969.96 and the Nasdaq Composite was up 0.86 percent at 4,847.023.
** FIAT CHRYSLER AUTOMOBILES NV, $14.81, +3.35 pct
Negotiators for the United Auto Workers and the company continued bargaining on Tuesday over wages and benefits for about 40,000 U.S. workers as the union delayed calling for strikes at the company’s most profitable operations.
** GW PHARMACEUTICALS PLC, $113.73, +6.39 pct
The UK-based company said its experimental cannabis drug for treating schizophrenia was found to be superior to a placebo in a mid-stage trial.
** FITBIT INC, $32.95, +2.97 pct
Pacific Crest Securities started covering the wearable device maker’s stock with an “overweight” rating and a price target of $47. Apple Inc’s current presence in fitness watches doesn’t represent a risk to FitBit, analysts wrote in a note. The company’s business is growing “ridiculously” fast and while consumer sales should drive the business, it can also expand in the corporate wellness market, they said.
** GRAY TELEVISION INC, $13.53, +15.25 pct
The broadcaster said it would acquire Schurz Communications Inc’s television and radio stations for $442.5 million. Gray Television said it expected the deal to add to its free cash flow.
** SILVER WHEATON CORP, $11.65, +4.48 pct
The Canadian company, which invests in miners in exchange for silver and gold, said it would buy back for cancellation up to 20.2 million shares on the Toronto and New York stock exchanges. The shares represent 5 percent of Silver Wheaton’s outstanding shares as of Sept. 11.
** EVOKE PHARMA INC, $3.8695, +15.51 pct
The specialty drug developer said that a late-stage trial design for its drug EVK-001 is consistent with the FDA’s guidelines. EVK-001 is used to treat gastroparesis, a condition in which the stomach takes too long to empty its contents.
** SUNEDISON INC, $11.13, +5.00 pct
Bank of America-Merrill Lynch (BofA-Merrill) resumed coverage of the company’s stock with a “buy” rating, saying future cash flows from SunEdison’s yieldco entities are undervalued. BofA-Merrill set a price objective of $18 on the stock and said it believed capital infusions from strategic and financial partners such as Dominion and JP Morgan would remain available to SunEdison to execute on development opportunities.
** MICROSOFT CORP, $43.89, +1.97 pct
The company sent out invitations on Monday for an event on Oct. 6, where it is expected to unveil new devices that run on Windows 10, its latest operating system. (Compiled by Manish Parashar in Bengaluru; Editing by Kirti Pandey)